Clinical Trial Update: Ozurdex for Macular Edema Post Membrane Peeling [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates a Phase 2/3 study of Ozurdex for macular edema following membrane peeling has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellophane Maculopathy
• Epiretinal Membrane
• Macular Edema
• Retinal Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Retina Specialists, PC | Conditions: Epiretinal Membrane, Cellophane Maculopathy | Phase 2, Phase 3 | Status: COMPLETED